Menopausal Hormone Therapy (MHT): Benefits, Risks, and Treatment Options

Menopausal hormone therapy (MHT), formerly called hormone replacement therapy (HRT), provides estrogen, progesterone, or a combination of both to women whose natural hormone levels have declined during menopause.

Why MHT Is Considered

Early research in the 1960s promoted MHT as a way to stay youthful after menopause, and use peaked in the 1990s. A 2002 Women’s Health Initiative (WHI) study linked MHT to higher rates of cancer and cardiovascular disease, causing a sharp decline in prescriptions across the U.S., U.K., and Canada. Subsequent analyses have clarified that the risks are lower—and the benefits greater—for women who start MHT before age 60 and within ten years of menopause.

Potential Benefits of MHT

Eases Menopausal Symptoms

For many women, MHT reduces hot flashes, night sweats, vaginal dryness, and sleep disturbances. Low‑dose estrogen, prasterone, or ospemifene are commonly used for symptom relief.

Cardiovascular Protection

When initiated early (within 10 years of menopause), MHT can improve lipid profiles and reduce the risk of coronary heart disease. A baseline cardiovascular exam is essential before starting therapy.

Mood Support

Estrogen therapy may serve as a second‑line treatment for depressive symptoms that arise during the menopausal transition.

Bone Health

Estrogen‑based MHT (often delivered via skin patch) for 1–2 years can increase bone mineral density and lower fracture risk.

Muscle Mass Preservation

Combined with regular exercise, MHT helps maintain lean muscle mass, supporting mobility and balance.

Neurological Benefits

A 2020 meta‑analysis suggests that early estrogen therapy may reduce the risk of Alzheimer’s and Parkinson’s diseases. Starting MHT after age 65 or more than a decade post‑menopause may increase dementia risk, so timing is crucial.

Known Risks

Cancer

Some studies associate certain MHT formulations with a modest increase in breast cancer risk, while estrogen‑plus‑progestin therapy may raise ovarian and endometrial cancer risk but appear to lower gastrointestinal cancer incidence. Ongoing research continues to refine these findings.

Blood Clots and Stroke

Oral and transdermal MHT can elevate the risk of venous thromboembolism and stroke, especially in women over 60 or those who begin therapy more than ten years after menopause. The risk rises with longer treatment duration, so the lowest effective dose for the shortest time is recommended.

Gallbladder Disease

Estrogen increases cholesterol concentration in the gallbladder, heightening the chance of gallstones. This risk is notable after five years of use but is not seen with transdermal estrogen.

When MHT May Not Be Suitable

Women with a history of any of the following should discuss alternatives with their healthcare provider before starting MHT:

• Breast, ovarian, or endometrial cancer
• Uncontrolled hypertension or cardiovascular disease
• History of blood clots or stroke
• Liver disease
• Active gallbladder disease

Forms and Brands of MHT

MHT is available in several delivery methods, each offering different dosing options:

• Pills
  • Estrogen only: Cenestin, Enjuvia, Estrace, Femtrace, Menest, Ortho‑Est, Premarin
  • Progesterone only: Prometrium, Provera
  • Combined estrogen + progesterone: Activella, Femhrt, Prefest, Prempro, Duavee
• Patches
  • Estrogen only: Alora, Climara, Estraderm, Minivelle, Vivelle
  • Combined: Climara Pro, Combipatch
• Injections
  • Estrogen: Delestrogen, Premarin
• Topical creams or sprays
  • Estrogen: Estrasorb, Evamist, Premarin
• Vaginal rings or creams
  • Estrogen: Estrace, Femring, Ogen, Premarin

Localized products (creams, rings) deliver hormone directly to the vagina, limiting systemic exposure and often reducing side‑effect risk.

Non‑Hormonal Alternatives

For women who prefer to avoid hormones, several options can lessen hot flashes and night sweats, including:

• Selective serotonin reuptake inhibitors (SSRIs) such as escitalopram
• Gabapentin
• Clonidine
• Lifestyle measures: regular exercise, cooling techniques, avoiding triggers like caffeine and alcohol

Discussing MHT With Your Provider

Preparing a brief list of questions can make the conversation smoother. Consider noting:

• Any personal or family history of cancer, heart disease, liver disease, or blood clots
• Current medications and supplements
• Allergies and past side‑effects from hormonal products
• Smoking status

Together, you and your clinician can weigh the potential benefits against the risks based on your age, time since menopause, and overall health.

Bottom Line

MHT can significantly improve quality of life for many women by easing vasomotor symptoms, protecting bone and muscle, and offering cardiovascular and mood benefits—especially when started before age 60 and within ten years of menopause. However, the therapy carries increased risks of certain cancers, blood clots, and gallbladder disease, particularly in older women or those who begin treatment later. A personalized evaluation with a healthcare professional is essential to determine whether MHT is the right choice for you.